Article Details
Retrieved on: 2021-07-01 03:45:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Chugai Pharmaceutical Co. filed an application for a treatment combining the use of the two monoclonal antibody drugs casirivimab and imdevimab.
Article found on: mainichi.jp
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here